rs5030721

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2

The NM_138554.5(TLR4):​c.1959G>A​(p.Lys653Lys) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0109 in 1,614,034 control chromosomes in the GnomAD database, including 117 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0083 ( 7 hom., cov: 32)
Exomes 𝑓: 0.011 ( 110 hom. )

Consequence

TLR4
NM_138554.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.391

Publications

9 publications found
Variant links:
Genes affected
TLR4 (HGNC:11850): (toll like receptor 4) The protein encoded by this gene is a member of the Toll-like receptor (TLR) family which plays a fundamental role in pathogen recognition and activation of innate immunity. TLRs are highly conserved from Drosophila to humans and share structural and functional similarities. They recognize pathogen-associated molecular patterns that are expressed on infectious agents, and mediate the production of cytokines necessary for the development of effective immunity. The various TLRs exhibit different patterns of expression. In silico studies have found a particularly strong binding of surface TLR4 with the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of Coronavirus disease-2019 (COVID-19). This receptor has also been implicated in signal transduction events induced by lipopolysaccharide (LPS) found in most gram-negative bacteria. Mutations in this gene have been associated with differences in LPS responsiveness, and with susceptibility to age-related macular degeneration. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2020]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.58).
BP6
Variant 9-117714087-G-A is Benign according to our data. Variant chr9-117714087-G-A is described in ClinVar as Benign. ClinVar VariationId is 786820.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.391 with no splicing effect.
BS2
High Homozygotes in GnomAd4 at 7 gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TLR4NM_138554.5 linkc.1959G>A p.Lys653Lys synonymous_variant Exon 3 of 3 ENST00000355622.8 NP_612564.1 O00206-1
TLR4NM_003266.4 linkc.1839G>A p.Lys613Lys synonymous_variant Exon 4 of 4 NP_003257.1 O00206-2
TLR4NM_138557.3 linkc.1359G>A p.Lys453Lys synonymous_variant Exon 2 of 2 NP_612567.1 O00206-3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TLR4ENST00000355622.8 linkc.1959G>A p.Lys653Lys synonymous_variant Exon 3 of 3 1 NM_138554.5 ENSP00000363089.5 O00206-1
ENSG00000285082ENST00000697666.1 linkc.140+5358G>A intron_variant Intron 3 of 4 ENSP00000513391.1 A0A8V8TMK6

Frequencies

GnomAD3 genomes
AF:
0.00829
AC:
1261
AN:
152140
Hom.:
7
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00183
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00687
Gnomad ASJ
AF:
0.000864
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.0118
Gnomad FIN
AF:
0.0187
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0118
Gnomad OTH
AF:
0.00669
GnomAD2 exomes
AF:
0.00896
AC:
2248
AN:
250906
AF XY:
0.00960
show subpopulations
Gnomad AFR exome
AF:
0.00154
Gnomad AMR exome
AF:
0.00640
Gnomad ASJ exome
AF:
0.00129
Gnomad EAS exome
AF:
0.000163
Gnomad FIN exome
AF:
0.0148
Gnomad NFE exome
AF:
0.0105
Gnomad OTH exome
AF:
0.00867
GnomAD4 exome
AF:
0.0112
AC:
16403
AN:
1461776
Hom.:
110
Cov.:
32
AF XY:
0.0112
AC XY:
8174
AN XY:
727188
show subpopulations
African (AFR)
AF:
0.00117
AC:
39
AN:
33476
American (AMR)
AF:
0.00626
AC:
280
AN:
44700
Ashkenazi Jewish (ASJ)
AF:
0.000995
AC:
26
AN:
26134
East Asian (EAS)
AF:
0.000101
AC:
4
AN:
39688
South Asian (SAS)
AF:
0.0131
AC:
1129
AN:
86254
European-Finnish (FIN)
AF:
0.0142
AC:
759
AN:
53384
Middle Eastern (MID)
AF:
0.00589
AC:
34
AN:
5768
European-Non Finnish (NFE)
AF:
0.0122
AC:
13548
AN:
1111986
Other (OTH)
AF:
0.00967
AC:
584
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
1025
2050
3076
4101
5126
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
522
1044
1566
2088
2610
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00828
AC:
1261
AN:
152258
Hom.:
7
Cov.:
32
AF XY:
0.00873
AC XY:
650
AN XY:
74446
show subpopulations
African (AFR)
AF:
0.00183
AC:
76
AN:
41546
American (AMR)
AF:
0.00686
AC:
105
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.000864
AC:
3
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5172
South Asian (SAS)
AF:
0.0118
AC:
57
AN:
4828
European-Finnish (FIN)
AF:
0.0187
AC:
198
AN:
10606
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0118
AC:
806
AN:
68018
Other (OTH)
AF:
0.00662
AC:
14
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
61
123
184
246
307
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00899
Hom.:
6
Bravo
AF:
0.00624
Asia WGS
AF:
0.00346
AC:
12
AN:
3478
EpiCase
AF:
0.0105
EpiControl
AF:
0.0103

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jan 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

TLR4: BP4, BP7, BS1, BS2 -

Aug 21, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.58
CADD
Benign
3.6
DANN
Benign
0.63
PhyloP100
0.39
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs5030721; hg19: chr9-120476365; API